Investor
Ideas #Potcasts, #Cannabis News and #Stocks on the Move; (NASDAQ: $HUGE) (CSE: $HUGE.C) (CSE: $HOLL.C) (CSE: $INDS.C) (TSXV: $KHRN.V)
(TSX: $LABS.TO)
Delta, Kelowna, BC, February 20, 2020 (Investorideas.com
Newswire) www.Investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast
edition of cannabis news and
stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2020/cannabis-potcasts/02201HUGE-HOLL-INDS-KHRN-LABS.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we look at a few public announcements.
But
first, High Times, the most
well-known brand in Cannabis, announced
today that it received notification from FINRA that it was
granted a trading symbol, clearing a final hurdle to begin trading. Company
trading will commence with a planned listing date to be determined in the near
future. The approval provides Hightimes Holding Corp. the ability to list on
the public markets which will culminate the brand’s highly successful
Regulation A + campaign.
“This is a big step
for the company and the High Times brand. The listing of the company’s stock
will give us a trading currency that will assist us in furthering our
acquisitional goals. There is no better time to roll out this next evolution as
we enter the cannabis retail space,” Adam Levin, Executive Chairman of
Hightimes Holding Corp., noted. “With the lessons we’ve learned from other
operator’s mistakes, great management, and the current state of the industry,
now is the time for High Times to thrive!“
“With over 23,000
investors, this has been one of the most widely subscribed to offerings in
history - across any industry,” Levin continued. “We’ve proven the strength of
our brand, and of the community we represent. We’re excited for this next step.”
High Times is
committed to continuing to connect cannabis to consumers with trusted products,
across price points, and has introduced several plans this year to support
that. High Times aims to cement its place as the largest name in cannabis and
become the ultimate destination for all consumers from the canna-curious to
marijuana lifers - both in-store and in person. The continued expansion in
licensing and e-commerce, and now into retail stores, allow the globally
recognized brand the unique opportunity to reach consumers wherever they may
live. With the first two retail stores launching in Los Angeles and Las Vegas,
High Times’s digital presence provides worldwide reach.
“This feels just
like my early days in ecommerce - except in this case we already have audience,
and we’re dealing with the most well-known brand in Cannabis,” Stormy Simon,
the brand’s Chief Executive Officer, stated. “My history in ecommerce should
help the company as we develop both our retail business as well as our direct
to consumer delivery options in markets across the globe.”
FSD Pharma Inc. (NASDAQ:
HUGE) (CSE:
HUGE) announced the
sale of its 12% equity interest in Cannara
Biotech Inc. (CSE:
LOVE) to a consortium of buyers for cash proceeds of more
than $7.7 million.
The
terms of the Share Sale Transaction were negotiated at arm's length with a
group of buyers that included entities controlled by members of the Cannara
board and senior management. A substantial portion of FSD Pharma's
shareholdings in Cannara were subject to a statutory escrow expiring December
2021. Under the terms of the Share Sale Transaction, the buyers agreed to
acquire FSD Pharma's interest subject to escrow and, as such, assumed all of
the associated market risk. The Share Sale Transaction represents a 670% return
on the Company's stake in Cannara.
"This
is a very positive milestone for the shareholders and stakeholders of FSD
Pharma to recognize a 7x return in less than two years," stated Raza
Bokhari, MD, Executive Co-Chairman & CEO. "This transaction
represents, which I hope is the first of others that will follow to strengthen
our cash position on the balance sheet. Our aim is to scale up to $50 million
in disposable cash through monetizing our non-cash assets and raising new
capital from institutional and institutional grade investors in the United
States and elsewhere."
Hollister
Biosciences Inc. (CSE:
HOLL), through its Hollister Cannabis Co division, announced the
launch of its 5-pack of .5g hash-infused pre-rolls, HashBone MiniBones.
HashBones are the
#1 hash-infused pre-roll in California. Each 1G HashBone is hand-packed with an
artisan blend of 25% cold water bubble hash and 75% top-shelf flower. Each
HashBone features a pair of sativa, hybrid or indica strains, boasting enhanced
flavor and potency. Flower is sourced from California's Central Coast, while
the cold-water bubble hash is made by Hollister.
The 5-pack of .5g
hash-infused pre-rolls, HashBone MiniBones, will be distributed exclusively by
Hollister Cannabis Co.'s distribution partner, Indus Holdings, Inc. (CSE:
INDS) and is anticipated to launch by April 01, 2020
HashBone MiniBones are expected to retail at an average price of $30 (plus
tax). Based on HashBone's current customer base, we forecast demand for 65,000
units in 2020.
The CEO of
Hollister Biosciences Inc., Carl Saling shared, "Our customers have been
requesting a multi pack HashBone that would be great on the go. We are thrilled
to launch the 5-pack mini bone hash infused pre rolls. "
Khiron Life
Sciences Corp. (TSXV:
KHRN) (OTCQB:
KHRNF) announced
today its intent to bring the Company's Kuida® CBD brand to
the Spanish market. This follows receipt of a "no objection" letter
from the TSXV specific to Spain, and is subject to meeting all regulatory
approvals in that country. With the previously announced fulfillment of E.U.
cosmetic notification regulatory requirements Khiron will prepare to commercialize
Kuida to a combined skincare market of over US$6.0 billion.
"As
our European operations ramp up, we are able to bring our unique products,
consumer experience and scientific capabilities from Latin America into one of
the world's fastest growing markets.
Entry for our Kuida brand into Spain, and later Switzerland, will represent
another milestone in the Company's strategy to serve consumers across multiple
categories and markets," comments Tejinder Virk, President, Khiron Europe.
Kuida,
the first consumer brand of Khiron's wellness business unit, brings the
benefits of cannabidiol (CBD) to a comprehensive portfolio of skin and body
care products for women. Kuida was launched in Colombia in October 2018 through
retail, wholesale and online channels and is now available nationwide and
through e-commerce channels. As the Company expands Kuida distribution in
Europe, an initial soft launch in the UK will be followed by a strategic
marketing and retail campaign. Kuida will be a featured exhibitor at Cosmoprof
Worldwide Bologna 2020, which attracted over 265,000 visitors in 2019 and is
the largest such event for attendees to learn more about market leading
products and to place orders.
MediPharm Labs
Corp. (TSX:
LABS) (OTCQX:
MEDIF) announced that
Shoppers Drug Mart, Canada’s leading pharmacy retailer, has selected its
wholly-owned subsidiary, MediPharm Labs Inc., to supply high-quality cannabis
concentrate products to medical patients nationally in Canada through its
online platform Medical Cannabis by Shoppers.
Under
the terms of the agreement, MediPharm will utilize its proprietary
pharmaceutical manufacturing platform, methodologies and scientific data to
provide Medical Cannabis by Shoppers with a wide range of concentrate-based
products starting with formulated bottled oils. MediPharm will provide other
derivative products such as gel caps and topicals as they become available. The
agreement is for a three-year term subject to renewal for an additional two
years. Formulated oils provided under the agreement are expected to begin being
shipped to Shoppers within the first two months of the agreement.
“MediPharm
Labs is proud to be partnering with one of Canada’s most trusted names in
retail to bring new and innovative pharmaceutical-quality cannabis concentrate
products to Shoppers’ medical consumers across Canada,” said Pat McCutcheon,
CEO, MediPharm Labs. “With our
pharmaceutically trained team, our GMP certified platform and research licence
permitting human trials, MediPharm Labs has the ability to develop advanced
cannabis products backed by proprietary scientific research that will serve as
the foundation for further expansion of future offerings.”
Medical
Cannabis by Shoppers launched in January 2019. The platform ships products from
Canadian licensed producers directly and discreetly to customers in all
provinces and territories in Canada. Under current regulations, pharmacists
cannot dispense medical cannabis from a pharmacy.
According
to Statistics Canada, approximately 1.1 million Canadians use cannabis for
medical purposes.i MediPharm Labs is pleased to partner with a
retailer who is not only committed to providing patients with high-quality
medical cannabis from a trusted source, but guidance from specialized advisors.
Such guidance is important in ensuring patients achieve satisfaction with their
customer experience.
Investor
ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com
website and this podcast is not an endorsement to buy products or services or
securities. Investors are reminded all investment involves risk and possible
loss of investment
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy:
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Cannabis Social Media
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment